Nephrology research at MedStar Health focuses on basic and clinical investigation into the advanced treatment of kidney diseases, including electrolyte disturbances and hypertension, and the care of those requiring renal replacement therapy, including dialysis and renal transplant patients. Many diseases affecting the kidney are systemic disorders not limited to the organ itself. The size and diversity of MedStar's research program, and the system's interdisciplinary focus on research, make the system a fertile laboratory for nephrology research.
Nephrology research includes:
- Studies to determine if new FDA-approved medicines or combinations of medicines are more effective than the current standard of practice.
- Trials of differing daily doses of an FDA-approved medicine to determine if the lower dose is equally effective (leading to fewer side effects).
- Studies involving new procedures or methods of providing care to enhance patient quality of life.
- Investigations involving improving disparities of care and eliminating barriers to care for medically underserved nephrology patient populations.
- Research into plasmapheresis, which enables greater compatibility for kidney transplantation
Nephrology researchers across MedStar Health work side by side with clinicians in the health system's transplant surgery program, which is located at MedStar Washington Hospital Center and MedStar Georgetown University Hospital. This is the largest and busiest kidney and kidney/pancreas transplantation program in the Washington metropolitan area, with more than 3,100 kidney or kidney/pancreas transplants, an average of more than 100 transplants each year, and survival rates that are among the best in the nation.